These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11466959)

  • 1. Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists.
    Brooks BR; Juhasz-Poscine K; Waclawik A; Sanjak M; Belden D; Roelke K; Parnell J; Weasler C
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():45-53; discussion 53-4. PubMed ID: 11466959
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot trial with clenbuterol in amyotrophic lateral sclerosis.
    Sorarù G; Pegoraro E; Spinella P; Turra S; D'Ascenzo C; Baggio L; Mantovan MC; Vergani L; Angelini C
    Amyotroph Lateral Scler; 2006 Dec; 7(4):246-8. PubMed ID: 17127564
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis.
    Teng YD; Choi H; Huang W; Onario RC; Frontera WR; Snyder EY; Sabharwal S
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):155-8. PubMed ID: 16388902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect].
    Puls I; Beck M; Giess R; Magnus T; Ochs G; Toyka KV
    Nervenarzt; 1999 Dec; 70(12):1112-5. PubMed ID: 10637819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
    Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
    Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic trial of beta 2-adrenergic agonist clenbuterol in muscular dystrophies].
    Oya Y; Ogawa M; Kawai M
    Rinsho Shinkeigaku; 2001 Oct; 41(10):698-700. PubMed ID: 11993192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clenbuterol: 'redistribution agent'].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1988 Sep; 132(39):1782-5. PubMed ID: 2903453
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.
    Barton PJ; Felkin LE; Birks EJ; Cullen ME; Banner NR; Grindle S; Hall JL; Miller LW; Yacoub MH
    Circulation; 2005 Aug; 112(9 Suppl):I46-50. PubMed ID: 16159864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clenbuterol retards loss of motor function in motor neuron degeneration mice.
    Zeman RJ; Peng H; Etlinger JD
    Exp Neurol; 2004 Jun; 187(2):460-7. PubMed ID: 15144872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist devices and drug therapy in heart failure.
    Rott D; Leibowitz D
    N Engl J Med; 2007 Feb; 356(8):871; author reply 871-2. PubMed ID: 17323455
    [No Abstract]   [Full Text] [Related]  

  • 11. Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia.
    Culmsee C; Junker V; Thal S; Kremers W; Maier S; Schneider HJ; Plesnila N; Krieglstein J
    Eur J Pharmacol; 2007 Dec; 575(1-3):57-65. PubMed ID: 17869242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2 agonists in the treatment of asthma.
    Yawn B
    Am Fam Physician; 2006 Jul; 74(2):232. PubMed ID: 16883922
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting beta-2 agonists in asthma.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):1-2. PubMed ID: 19122566
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of B2-agonists action and safety aspects].
    Chorostowska-Wynimko J
    Pol Merkur Lekarski; 2002 Jun; 12(72):441-4. PubMed ID: 12362656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clenbuterol impairs muscle quality and is potentially dangerous.
    Habedank D; Steeg M; Anker SD
    J Heart Lung Transplant; 2008 Aug; 27(8):934-5. PubMed ID: 18656813
    [No Abstract]   [Full Text] [Related]  

  • 16. A pharmacodynamic study on clenbuterol-induced toxicity: beta1- and beta2-adrenoceptors involvement in guinea-pig tachycardia in an in vitro model.
    Mazzanti G; Di Sotto A; Daniele C; Battinelli L; Brambilla G; Fiori M; Loizzo S; Loizzo A
    Food Chem Toxicol; 2007 Sep; 45(9):1694-9. PubMed ID: 17449161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan.
    Lenard NR; Gettys TW; Dunn AJ
    J Pharmacol Exp Ther; 2003 May; 305(2):653-9. PubMed ID: 12606631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regarding "Differential control of T(H)1 versus T(H)2 cell responses by the combination of low-dose steroids with beta(2)-adrenergic agonists".
    Friesen JH; Ameredes BT; Calhoun WJ
    J Allergy Clin Immunol; 2005 Feb; 115(2):424; author reply 425. PubMed ID: 15696109
    [No Abstract]   [Full Text] [Related]  

  • 19. Cough and asthma: the role of inhaled corticosteroids and beta2-agonists.
    Cazzola M; Gabriella Matera M
    Ther Adv Respir Dis; 2008 Feb; 2(1):7-11. PubMed ID: 19124354
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phenotypic variation in ALS].
    Sasaki S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):825-7. PubMed ID: 17432191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.